Subvenite Alternatives Compared
| Subvenite (lamotrigine) | Vraylar (cariprazine) | Lybalvi (olanzapine / samidorphan) |
|
|---|
| Subvenite (lamotrigine) | Vraylar (cariprazine) | Lybalvi (olanzapine / samidorphan) |
|
|---|---|---|---|
|
Prescription only
Prescribed for Bipolar Disorder, Epilepsy, Lennox-Gastaut Syndrome, Seizure Prevention. Subvenite may also be used for purposes not listed in this medication guide. |
Prescription only
Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to... View more |
Prescription only
Prescribed for Bipolar Disorder, Schizophrenia. Lybalvi may also be used for purposes not listed in this medication guide. |
|
| More about Subvenite (lamotrigine) | More about Vraylar (cariprazine) | More about Lybalvi (olanzapine / samidorphan) | |
| Ratings & Reviews | |||
|
Be the first to share your experience with this drug. |
Vraylar has an average rating of 6.0 out of 10 from a total of 509 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 34% reported a negative effect. |
Lybalvi has an average rating of 8.0 out of 10 from a total of 16 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 7% reported a negative effect. |
|
| Drug Class | |||
|
None |
|||
| Side Effects | |||
| Generic Availability | |||
| Lower cost generic approved | |||
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms Available | |||
|
N/A |
|
N/A |
|
| Brand Names | |||
| Other lamotrigine brands include: Lamictal, Lamictal CD, Lamictal ODT, Lamictal XR |
N/A |
N/A |
|
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||
|
25.7 hours |
504 hours |
54 hours (empirically) |
|
| CSA Schedule ** View glossary of terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | |||
|
A total of 286 drugs are known to interact with Subvenite:
|
A total of 571 drugs are known to interact with Vraylar:
|
A total of 696 drugs are known to interact with Lybalvi:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
|
||
| Disease Interactions | |||
| First Approval Date | |||
|
N/A |
September 17, 2015 |
May 28, 2021 |
|
| WADA Class View World Anti-Doping Agency classifications. | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient resources | |||
| Professional Resources | |||
| Related Treatment Guide | |||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.